No Data
Concerned about falling behind eli lilly and co (LLY.US) and novo-nordisk a/s (NVO.US), the team in india urges to launch Wegovy in india as soon as possible.
Due to concerns about falling behind competitor eli lilly and co in the potentially huge market in india, the indian team of the danish pharmaceutical giant novo-nordisk a/s has been pushing for the earlier launch of its popular weight-loss drug Wegovy in india.
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
December Starts With a Mixed Market | Live Stock
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $994
Eli Lilly & Co (LLY) Gets a Buy From Jefferies
Coach Donnie OP : Let’s GOOO
cryptonerd : Extremely informative![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Coach Donnie OP cryptonerd : What crypto or stocks would you add?
cryptonerd Coach Donnie OP : Still a strong believer of XRP and XLM because of their fundamentals and growth prospect. Feel ADA have loads of potential as well, good to add in your portfolio to diversify.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Definitely agree with you on holding Palantir and Tesla
Coach Donnie OP cryptonerd : Glad I got all the above
well said Bro 
View more comments...